Oct 22, 2024, 08:27 AM by

Seer’s Proteograph™ Product Suite reveals new insights into Alzheimer’s pathways, drives population-scale plasma analysis, and captures immune dynamics in xenotransplantation—with additional breakthrough research from collaborators advancing proteomic discovery at scale

Oct 18, 2024, 09:10 AM by

DNA Script announces Marc Montserrat's appointment as CEO.

Oct 18, 2024, 09:10 AM by

Launching at HLTH 2024, the groundbreaking partnership offers payers, health systems, employers, and life science organizations access to personalized obesity care and treatment planning based on a patient’s DNA.

Oct 18, 2024, 09:10 AM by

Oct 17, 2024, 08:31 AM by

Healthcasts, the leading online community for healthcare professional consultation and real-world experience, today announced the appointment of Max Baumer, CPA, as Chief Operating Officer and Chief Financial Officer. Baumer has spent over a decade overseeing finance and operations for companies experiencing exceptional growth including large hospital systems and healthcare staffing companies, making him uniquely positioned to bridge financial and operational duties in his role at Healthcasts.

Oct 17, 2024, 08:31 AM by

Oct 17, 2024, 01:00 AM by User Not Found

Bio-IT World | Illumina unveiled its MiSeq i100 Series of sequencing systems last week during an online customer event, comprising two new benchtop instruments: MiSeq i100 and MiSeq i100 Plus Systems. The MiSeq i100 will be available to ship globally in 2025.

Oct 16, 2024, 15:18 PM by User Not Found

Bio-IT World | As artificial intelligence (AI) and machine learning (ML) become increasingly prevalent in the industry, there are still several concerns about its implementation. Mainly, how safe is it to use AI? What measures can be taken to increase and reinforce security? The Pistoia Alliance decided to find out.

Oct 16, 2024, 08:22 AM by

Oct 16, 2024, 08:22 AM by

Oct 15, 2024, 16:06 PM by

Oxford University Hospitals NHS Foundation Trust (OUH) accelerates their Digital by Default strategy by harnessing PhenoTips’ cloud-hosted Genomic Health Record to digitise, integrate, and standardise genomic care.

Oct 15, 2024, 15:03 PM by User Not Found

Bio-IT World | The clinical utility of treating cancer by modulating the estrogen receptor could radically and quickly expand, initially for patients with triple-negative breast cancer but potentially thereafter to those with melanoma and cancers found in the colon, lung, head, and neck. Hope springs from findings emerging from the lab of Professor Donald McDonnell, Ph.D., at Duke University School of Medicine, where the field of oral selective estrogen down-regulators was pioneered nearly two decades ago.

Oct 15, 2024, 10:18 AM by

PHARMASEAL specializes in state-of-the-art trial management software for life sciences (unified CTMS/eTMF) and LEDGER RUN, INC., an innovative technology company focused on optimizing clinical operations in the areas of site budgeting, contracts and payments, announced their partnership today. Through the partnership, PHARMASEAL’S Engility® Platform software Engility CTMS, Engility eTMF and LEDGER RUN'S unique ClinRun™ platform will streamline and enhance clinical operation budgeting and payment processes with an intelligent approach and seamless integration.

Oct 15, 2024, 10:18 AM by

Sapio Sciences, the science-aware™ lab informatics platform, today announced the addition of new immunogenicity bioanalysis features to its industry-leading lab informatics platform. These new capabilities in the Sapio LIMS (Laboratory Information Management System) and Sapio ELN (Electronic Lab Notebook) solutions streamline testing workflows for detecting anti-drug antibodies (ADA) and neutralizing antibodies (NAb).

Oct 15, 2024, 09:17 AM by

Oct 11, 2024, 01:00 AM by User Not Found

Bio-IT World | In early 2024, it was revealed that contract research and manufacturing organization WuXi Apptec had allegedly shared intellectual property with the Chinese government without their client’s consent. This breach of trust generated widespread concern and backlash, bringing renewed attention to the importance of proper data management and data sharing in the biotech and pharmaceutical industries.

Oct 10, 2024, 08:01 AM by

Oct 10, 2024, 08:01 AM by

Exothera has announced the appointment of a new CEO, Cédric Volanti.

Oct 9, 2024, 08:31 AM by

New Platform Reduces IND Submission Timelines for Small and Mid-Sized Pharma Companies.

Oct 8, 2024, 08:36 AM by

Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, announces the acquisition of Alderley Analytical Ltd, reflecting an important milestone in Synexa’s ‘buy and build’ growth strategy. By combining the two complementary companies, the group can now offer an even more comprehensive range of services to an enlarged customer base, both in large and small molecule drug development, and ranging from pre-clinical work to phase III clinical studies.